GC Biopharma Stock

GC Biopharma EBITDA per Share

The EBITDA per Share of GC Biopharma (006280.KS) as of Aug 13, 2026 is 4,076.01 KRW. In the previous year, EBITDA per Share was 4,076.70 KRW — a change of -0.02% (lower).

EBITDA per Share

4,076.01KRW

YoY

-0.02%

Last updated:

EBITDA per Share of GC Biopharma is 2026 4,076.01 KRW. EBITDA per Share of GC Biopharma was 2025 4,076.70 KRW. It decreases by -0.02% lower compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

GC Biopharma Stock analysis

What does GC Biopharma do? GC Biopharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GC Biopharma stock

EBITDA per Share of GC Biopharma is 4,076.01 KRW in 2026.

EBITDA per Share of GC Biopharma changed from 4,076.70 KRW to 4,076.01 KRW, representing a -0.02% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share GC Biopharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — GC Biopharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — GC Biopharma